Canopy Network raised $8.5 million and acquired Tanssi tech as it prepares mainnet and expands AI-native tools for onchain ...

Backstage solved the portal problem, not the platform problem. A portal organizes catalogs, documentation, and templates. A ...

Foundational web development practices still shape how websites and web applications perform, protect users and hold up when ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Yet another detail about the next-gen Xbox console has apparently ...

The Procter & Gamble Company (NYSE:PG) was among the stocks Jim Cramer discussed on Mad Money, along with the recent sell-off in the market. Cramer mentioned the stock during the episode and remarked: ...

Prologis (PLD), known as an industrial REIT, has built the company to include several adjacent businesses to provide strategic advantages, management said Tuesday at Nareit's REITweek conference. With ...

Attackers have reduced the time to develop an exploit for a known vulnerability from 125 days to a mere half a day, thanks to the use of AI-assisted development, leaving vulnerability scanners ...

Mostly along party lines, the U.S. Senate approved Warsh's appointment by a vote of 54-45. While Warsh has had to walk a fine line to reach the top position at the Federal Reserve's Board of Governors ...

New World Development Co., the cash-strapped property developer, is in talks to sell its 50% stake in a portfolio of three Hong Kong hotels valued at $2 billion, people familiar with the matter said.

Forget the 60/40 portfolio: Investors have had a much better option this year to get better diversification and stronger returns. Rather than the traditional split between stocks and fixed income, ...

OpenAI’s Codex has revolutionized the way we think about building websites, transforming complex coding tasks into simple conversations. It allows you, complete beginners and seasoned developers, to ...

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...